New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
09:06 EDTACADACADIA price target raised to $42 from $28 at Piper Jaffray
Piper Jaffray raised its price target for ACADIA Pharmaceuticals to $42 citing the company's pipeline progress following its Q4 results. The firm keeps an Overweight rating on the stock.
News For ACAD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
07:18 EDTACADAmerican Academy of Neurology to hold annual meeting
Subscribe for More Information
April 16, 2015
10:00 EDTACADOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:38 EDTACADACADIA initiated with an Outperform at Leerink
Leerink started shares of ACADIA with an Outperform rating saying the recent pullback following the pimavanserin new drug application delay provides a buying opportunity. The firm set a $48 price target for the stock.
April 14, 2015
07:05 EDTACADNeedham to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use